project id: TCGA-ESCA; case submitter id: TCGA-VR-A8EY; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.47; rna integrity number: 7.5; age at index: 44; days to birth: -16255; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1968; age at diagnosis: 16255; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical stage: Stage IIA; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1025.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 563; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-VR-A8EY-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 4.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 96.0; percent tumor nuclei: 70.0;